RCE 2.13% 46.0¢ recce pharmaceuticals ltd

Ann: Patients to be Dosed in Ph 1 IV Clinical Trial of R327, page-7

  1. 40 Posts.
    lightbulb Created with Sketch. 13
    Everything seems to be lining up nicely. However I would say the 'significant de-risking' occurs when positive IV trials come in. Not to say the burn trial updaters aren't encouraging. But with positive IV results we should expect some big eyes on us. GL to all.
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.